Covered recipient · General Payments record
SHAILESH R SATPUTE
Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology
General Payments · PY2018–2024
$14,286.76
- Reported across 744 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,353.50 | 49 |
| Education | $13.04 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $171.33 | 9 |
| Daiichi Sankyo Inc. | $140.31 | 2 |
| Acerta Pharma LLC | $106.43 | 5 |
| Adaptive Biotechnologies Corporation | $87.03 | 1 |
| Celgene Corporation | $70.94 | 3 |
| ABBVIE INC. | $67.42 | 3 |
| Takeda Pharmaceuticals U.S.A., Inc. | $63.52 | 2 |
| GlaxoSmithKline, LLC. | $63.38 | 2 |
| GENZYME CORPORATION | $53.16 | 1 |
| Janssen Biotech, Inc. | $52.35 | 2 |
| PUMA BIOTECHNOLOGY, INC. | $46.65 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $45.35 | 2 |
| Alexion Pharmaceuticals, Inc. | $34.59 | 1 |
| Astellas Pharma US Inc | $29.72 | 1 |
| Bayer HealthCare Pharmaceuticals Inc. | $29.49 | 1 |
| Ipsen Biopharmaceuticals, Inc | $29.37 | 1 |
| Blueprint Medicines Corporation | $25.72 | 1 |
| EISAI INC. | $24.80 | 1 |
| Merck Sharp & Dohme Corporation | $24.47 | 1 |
| BeiGene USA, Inc. | $24.24 | 1 |
| Mirati Therapeutics, Inc. | $23.95 | 1 |
| Stemline Therapeutics Inc. | $22.91 | 1 |
| Karyopharm Therapeutics Inc. | $22.00 | 1 |
| Genentech USA, Inc. | $21.93 | 1 |
| Pharmacosmos Therapeutics Inc. | $21.71 | 1 |
| Deciphera Pharmaceuticals Inc. | $21.47 | 1 |
| Legend Biotech USA Inc. | $21.45 | 1 |
| Lilly USA, LLC | $20.85 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (50)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.